Chronic kidney disease

K Kalantar-Zadeh, TH Jafar, D Nitsch, BL Neuen… - The lancet, 2021 - thelancet.com
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …

Lupus nephritis

HJ Anders, R Saxena, M Zhao, I Parodis… - Nature reviews Disease …, 2020 - nature.com
Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe
organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most …

[HTML][HTML] KDIGO 2021 clinical practice guideline for the management of glomerular diseases

BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - kidney-international.org
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA …

A Fanouriakis, M Kostopoulou, K Cheema… - Annals of the …, 2020 - ard.bmj.com
Objective To update the 2012 EULAR/ERA–EDTA recommendations for the management of
lupus nephritis (LN). Methods Following the EULAR standardised operating procedures, a …

Membranous nephropathy: new pathogenic mechanisms and their clinical implications

E Hoxha, L Reinhard, RAK Stahl - Nature Reviews Nephrology, 2022 - nature.com
Membranous nephropathy (MN) is characterized histomorphologically by the presence of
immune deposits in the subepithelial space of the glomerular filtration barrier; its clinical …

IgA nephropathy: an interesting autoimmune kidney disease

A Rajasekaran, BA Julian, DV Rizk - The American journal of the medical …, 2021 - Elsevier
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide. It is a leading cause of chronic kidney disease and progresses to end-stage …

[HTML][HTML] Rituximab for the treatment of multiple sclerosis: a review

CG Chisari, E Sgarlata, S Arena, S Toscano, M Luca… - Journal of …, 2022 - Springer
In the last decades, evidence suggesting the direct or indirect involvement of B cells on
multiple sclerosis (MS) pathogenesis has accumulated. The increased amount of data on …

Rituximab or cyclophosphamide in the treatment of membranous nephropathy: the RI-CYCLO randomized trial

F Scolari, E Delbarba, D Santoro… - Journal of the …, 2021 - journals.lww.com
Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for
membranous nephropathy. Compared with this regimen, rituximab therapy might have a …

[HTML][HTML] Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy

S Sethi, H Debiec, B Madden, MC Charlesworth… - Kidney international, 2020 - Elsevier
Membranous nephropathy is characterized by deposition of immune complexes along the
glomerular basement membrane. PLA2R and THSD7A are target antigens in 70% and 1-5 …

[HTML][HTML] Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders

C Kaegi, B Wuest, J Schreiner, UC Steiner… - Frontiers in …, 2019 - frontiersin.org
Background: During the past years biologic agents (also termed biologicals or biologics)
have become a crucial treatment option in immunological diseases. Numerous articles have …